Skip to main content

Table 3 Average provider costs (% of total), mean patient costs (95% confidence interval) and financing (% of total), US$*

From: Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa

Average provider costs

PWP model

PNP model

Purely public model

 

Site 1

Site 2

Site 3

Site 4

Site 5

Site 6

 

N = 95

N = 423

N = 355

N = 50

N = 85

N = 174

Hospital stay**

220 (34%)

N.A.††

N.A.

N.A.

N.A.

N.A.

Health clinic visits for monitoring**

14 (2.1%)

18 (2.4%)

23 (9%)

24 (9%)

19 (4%)

20 (3%)

Health clinic visits for DOT**

334 (51%)

301 (40%)

36 (14%)

39 (16%)

426 (84%)

485 (85%)

Visits to 'treatment supporters'**

N.A.

N.A.

55 (22%)

55 (22%)

N.A.

N.A.

Sputum smears†

12 (1.8%)

14 (1.8%)

16 (7%)

16 (7%)

16 (3%)

16 (3%)

Sputum culture†

16 (2.4%)

17 (2.3%)

N.A.

N.A.

N.A.

N.A.

Drugs

46 (7%)

383 (52%)

46 (18%)

46 (18%)

46 (9%)

46 (8%)

X-rays†

12 (1.8%)

11 (1.5%)

N.A.

N.A.

N.A.

N.A.

Overall supervision of community-based programme

N.A.

N.A.

74 (29%)

72 (28%)

N.A.

N.A.

Training for community 'treatment supporters'

N.A.

N.A.

1 (0.4%)

1 (0.4%)

N.A.

N.A.

Total cost per patient

654

744

251

253

507

568

Mean patient cost

      

Visits to clinic for monitoring and DOT

      

Travel cost

N/A

N/A

2.1 (1.7–2.4)

2.6 (2.3–3.2)

26.2 (25.1–27.6)

20.3 (18.6–23.8)

Time cost

N/A

N/A

6.2 (4.0–8.3)

5.9 (4.6–6.5)

75.6 (71.8–78.2)

101.9 (94.4–115.1)

Visits to 'treatment supporter' for DOT

      

Travel cost

N/A

N/A

0

0

N.A.

N.A.

Time cost

N/A

N/A

30.9 (23.6–36.8)

28.2 (24.9–30.5)

N.A.

N.A.

Total cost per patient

N/A

N/A

39.2 (28.3–47.5)

36.7 (31.8–40.2)

101.8 (96.9–105.8)

122.2 (113.0–138.9)

Financing of treatment cost

      

Public provider

N.A.

N.A.

59 (20%)

63 (20%)

445 (73%)

506 (73%)

Private provider

609 (93%)

708 (95%)

121 (42%)

114 (39%)

N.A.

N.A.

Provincial TB programme‡

46 (7%)

36 (5%)

71 (24%)

76 (27%)

62 (10%)

62 (9%)

Patient

N.A.

N.A.

39 (13%)

37 (13%)

102 (17%)

122 (18%)

Total cost per patient

654

744

290

290

609

690

  1. * Cost data from 2001. Average exchange rate prevailing in 2001 US$1 = R8.57.
  2. ** Expected number of visits/hospital days for each site is as follows: 7 hospital days for site 1; 3 visits for monitoring at each site except at site 1 where there are only 2 such visits; 130 visits for DOT (sites 2, 5 and 6), 123 visits for DOT (site 1), and 10 visits for DOT (sites 3 and 4); 120 visits to 'treatment supporter' (sites 3 and 4).
  3. † Expected number of diagnostic tests for each site: 4 sputum smears (site 1), 7 sputum smears (site 2), and 4 sputum smears (sites 4–6); 1 sputum culture (sites 1 and 2); 3 X-rays (sites 1 and 2).
  4. †† N.A. = not applicable.
  5. ‡ Provincial TB programme covered the cost of drugs in all the sites except in site 2 where a reimbursement on a patient day basis was provided. In addition to the drugs, the programme also covered the cost of diagnostic tests in sites 3–6.
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us